The Orbital Fibroblast: A Key Player and Target for Therapy in Graves' Ophthalmopathy

被引：29
|
作者：
van Steensel, Leendert [1 ]
Dik, Willem A. [1 ]
机构：
[1] Erasmus MC, Dept Immunol, POB 2040, NL-3000 CA Rotterdam, Netherlands
来源：
ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY | 2010年 / 29卷 / 04期
关键词：
Graves' Ophthalmopathy; Orbital fibroblast; PDGF; Therapy; Pathogenesis;
D O I：
10.3109/01676831003668443
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Orbital fibroblasts play a key role in the pathogenesis of Graves' ophthalmopathy (GO). We discuss some major aspects by which orbital fibroblasts contribute to GO and the important role of PDGF-BB herein. Finally, we propose the orbital fibroblast, and especially the PDGF system acting on orbital fibroblasts, as an important therapeutic target in GO.
引用
收藏
页码：202 / 206
页数：5
相关论文
共 50 条
  • [31] Gypenosides Protect Orbital Fibroblasts in Graves Ophthalmopathy via Anti-Inflammation and Anti-Fibrosis Effects
    Li, Haoyu
    Ma, Chao
    Liu, Wei
    He, Jianfeng
    Li, Kaijun
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (05)
  • [32] INTRAVENOUS METHYLPREDNISOLONE PULSE THERAPY FOR GRAVES OPHTHALMOPATHY
    HIROMATSU, Y
    TANAKA, K
    SATO, M
    KUROKI, T
    NONAKA, K
    KOJIMA, K
    NISHIMURA, H
    NISHIDA, H
    KAISE, N
    ENDOCRINE JOURNAL, 1993, 40 (01) : 63 - 72
  • [33] Diagnosis and therapy in Graves' Ophthalmopathy - Consensus guidelines
    Ramschak-Schwarzer, S
    Langmann, A
    Lindner, S
    Prettenhofer, U
    Moncayo, R
    Baldissera, I
    Lind, P
    Ettl, A
    Maschek, W
    Pichler, R
    Weissel, M
    Leb, G
    ACTA MEDICA AUSTRIACA, 2002, 29 (04) : 117 - 119
  • [34] Relationships of orbital computed tomographic findings and activity scores to the prognosis of corticosteroid therapy in patients with Graves' ophthalmopathy
    Chang, TC
    Huang, KH
    Hsiao, YL
    Tzeng, SS
    Kao, SCS
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 1997, 75 (03): : 301 - 304
  • [35] Superoxide radical production stimulates retroocular fibroblast proliferation in Graves' ophthalmopathy
    Burch, HB
    Lahiri, S
    Bahn, RS
    Barnes, S
    EXPERIMENTAL EYE RESEARCH, 1997, 65 (02) : 311 - 316
  • [36] MODULATION OF GRAVES ORBITAL FIBROBLAST PROLIFERATION BY CYTOKINES AND GLUCOCORTICOID RECEPTOR AGONISTS
    HEUFELDER, AE
    BAHN, RS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (01) : 120 - 127
  • [37] Oxidative stress and antioxidant activity in orbital fibroadipose tissue in graves' ophthalmopathy
    Hondur, Ahmet
    Konuk, Onur
    Dincel, Aylin Sepici
    Bilgihan, Ayse
    Unal, Mehmet
    Hasanreisoglu, Berati
    CURRENT EYE RESEARCH, 2008, 33 (5-6) : 421 - 427
  • [38] Clinical outcomes of graves' ophthalmopathy treated with intensity modulated radiation therapy
    Li, Yong-Jiang
    Luo, Yong
    He, Wei-Min
    Li, Ping
    Wang, Feng
    RADIATION ONCOLOGY, 2017, 12
  • [39] Three-wall orbital decompression in Graves ophthalmopathy for improvement of vision
    Lee, TJ
    Kang, MH
    Hong, JP
    JOURNAL OF CRANIOFACIAL SURGERY, 2003, 14 (04) : 500 - 503
  • [40] Increased response to oxidative stress challenge in Graves' ophthalmopathy orbital fibroblasts
    Tsai, Chieh-Chih
    Wu, Shi-Bei
    Cheng, Ching-Yu
    Kao, Shu-Ching
    Kau, Hui-Chuan
    Lee, Shui-Mei
    Wei, Yau-Huei
    MOLECULAR VISION, 2011, 17 (302-03): : 2782 - 2788
12345